Thyroid Disorders in Malaysia: A Nationwide Multicentre Study

NCT ID: NCT02190214

Last Updated: 2016-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2498 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-08-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This will be a population based study looking at the prevalence of thyroid disorders in Malaysia (including hypo- and hyperthyroidism, subclinical hypo- or hyperthyroidism) and its association with different ethnicity and iodine status. The study will also look at genetic susceptibility for autoimmune thyroid disorders in the Malaysian population

General hypotheses:

The prevalence of thyroid disorders in Malaysia is 10% for hypothyroidism and 2% for hyperthyroidism Hypo- and hyperthyroidism is associated with iodine status in our population There are different susceptibility gene for autoimmune thyroid disorder in different ethnicity in our population

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a cross-sectional population based study involving Malaysian adults (aged 18 year old and above). Cluster sampling will be used to select respondents that will be representative of the Malaysian population. Selected respondent will be interviewed, anthropometric measurement taken, blood and urine sample taken.

Blood will be analyzed for thyroid function (thyroxine, triiodothyronine and thyroid stimulating hormone), autoantibodies (anti-thyroperoxidase and anti-thyroglobulin). Urine will be analyzed for urinary iodine.

Those diagnosed with autoimmune thyroid disorders with strong family history of thyroid disorders (multiplex multi-generation family involvement) will have their blood sent for whole exome sequencing and linkage analysis done to identify possible susceptible gene for autoimmune thyroid disorders

Respondents detected to have hypo- or hyper- and subclinical hypo- or hyperthyroidism will be referred to their nearest health centre for further evaluation and treatment appropriate for their condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypothyroidism Subclinical Hypothyroidism Hyperthyroidism Subclinical Hyperthyroidism Graves Disease Hashimoto's Thyroiditis Iodine Deficiency Genetic Susceptibility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged equal or more than 18 years old at the time of sampling
* Malaysian citizen

Exclusion Criteria

* Respondents who did not give consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Malaysian Endocrine and Metabolic Society

OTHER

Sponsor Role collaborator

National University of Malaysia

OTHER

Sponsor Role collaborator

University of Malaya

OTHER

Sponsor Role collaborator

IMU University, Malaysia

OTHER

Sponsor Role collaborator

International Islamic University Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Mohamnmad Arif Shahar

Assist Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nor Azmi Kamaruddin, MBBS, MMed

Role: PRINCIPAL_INVESTIGATOR

National University of Malaysia

Norlela Sukor, MMed, Phd

Role: PRINCIPAL_INVESTIGATOR

National University of Malaysia

Norhanita Othman

Role: PRINCIPAL_INVESTIGATOR

National University of Malaysia

Johari Ali

Role: PRINCIPAL_INVESTIGATOR

University of Malaya

Shirenee Vethakkan

Role: PRINCIPAL_INVESTIGATOR

University of Malaya

Siew Kim Kwa

Role: PRINCIPAL_INVESTIGATOR

IMU University, Malaysia

Kuck Meng Chong, MD

Role: PRINCIPAL_INVESTIGATOR

Malaysian Endocrine and Metabolic Society

Lecthuman Ramanathan

Role: PRINCIPAL_INVESTIGATOR

Malaysian Endocrine and Metabolic Society

Hussein Zanariah

Role: PRINCIPAL_INVESTIGATOR

Malaysian Endocrine and Metabolic Society

Nurain Mohd Noor

Role: PRINCIPAL_INVESTIGATOR

Malaysian Endocrine and Metabolic Society

Norhaliza Mohd Ali

Role: PRINCIPAL_INVESTIGATOR

Malaysian Endocrine and Metabolic Society

Norhayati Yahya

Role: PRINCIPAL_INVESTIGATOR

Malaysian Endocrine and Metabolic Society

Nor Azizah Aziz

Role: PRINCIPAL_INVESTIGATOR

Malaysian Endocrine and Metabolic Society

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MyEndo-Thyroid

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.